Cite
HARVARD Citation
Clark, K. et al. (n.d.). TRB‐J1 usage, in combination with the HLA‐A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates. International journal of immunogenetics. pp. 31-37. [Online].